Genstar Therapeutics, Vascular Genetics deal

Gene therapy companies Vascular Genetics and GNT will merge in a stock-for-stock deal. The combined company, to be called Autus

Read the full 202 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE